Chinese Academy of Sciences

Fudan University

Advanced Micro-fabrication Equipment Inc. China

Shanghai Pharmaceuticals Holding Co., Ltd.

Huawei Technologies Co., Limited

Via Alliance Semiconductor Co., Ltd.

Glenfly Tech Co., Ltd.

Shanxi Jinbo Bio-pharmaceutical Co., Ltd.

Jiangsu Huaiyu Pharmaceutical Co., Ltd.

Qian Wang

Guangxin Xia

Yanjun Liu

Yu Mao

Yanjie Wang

Chenyang Zhu

Hui Ge

Zhixiong Xiang

Yanan Han

Guoyong Huo

Chen Shi

Xiong Zhai

Xuemei Liao

Tuqiang Q Ni

Peng Wang

Wei Ruan

Li Fei Zheng

Jian Yuan Wu

Cong Chen

Zhitang Song

Jie Zhou

Xi Li

Lina Xu

Ting Wang

Lile Liu

Qing Duan

Xinhong Cheng

Dan Wang

Yuehui Yu

Tatchi Teddy Yang

Meiling Wang

Xia Yang

Zhongjian Wang

Houpeng Chen

Shibo Jiang

Lu Lu

Yu Lei

Yizhun Zhu

Yichun Zhu

Xiaohui Shao

Yuandong Wang

Zezhong Liu

Heng Tao

Qing Mu

Larry Lei

Ningning Song

Xiaojiao Bian

Peipei Wei

Yajun Huang

Lingyan Shen

Duo Cao

Zhenrui He

Dongliang Zhang

Jingjie Li

A Wi-Fi communication method and a device are disclosed, and relate to the field of wireless communication technologies. According to the method, a first communication device is configured to: generate a physical frame, and send the physical frame. The physical frame includes signaling information and a plurality of training sequences used for channel estimation, the signaling information indicates a quantity of space-time streams and a quantity of the plurality of training sequences, and the quantity of the plurality of training sequences is greater than the quantity of space-time streams. This helps improve accuracy of an algorithm such as channel estimation in a communication system, to improve a demodulation capability of a communication device, and ensure data demodulation effect.

Wi-Fi communication method and device

Provided are a fusion protein and use thereof. Provided is a fusion protein, comprising a trimerization block and an immunogenic block which are connected by a linker, wherein the trimerization block comprises one or more of repeat units set forth in SEQ ID NO. 1; the immunogenic block is an immunogenic protein of a pathogen, for example, being selected from a coronavirus RBD block, an HIV membrane protein or an influenza virus hemagglutinin protein, and immunogenic fragments thereof. Compared with an immunogen monomer, the trimer can generate a higher neutralizing antibody level, does not induce a strong antibody against the trimerization block in a human body, and can promote the immune response of the organism to be focused on the immunogenic block.

Fusion protein and use thereof

Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.

Anti-human LAG-3 monoclonal antibody and use thereof

Embodiments of the present disclosure provide a plasma processing system, comprising: a transfer chamber, the transfer chamber including a plurality of sidewalls, each sidewall being connected with a plurality of process chambers; each process chamber including a base therein, the base including a central point; wherein at least two process chambers connected to a same sidewall form one process chamber group, wherein a first distance is provided between the central points of two bases in a first process chamber group, and a second distance is provided between the central points of two bases in a second process chamber group, the first distance being greater than the second distance; and the transfer chamber comprises a mechanical transfer device; a rotating pedestal includes two independently movable robot arms thereon, the two robot arms; and the two robot arms both include a plurality of rotating shafts and a plurality of rotating arms, wherein a remote rotating arm of each robot arm further includes an end effector for holding a substrate. The mechanical transfer device according to the present disclosure may simultaneously retrieve and place the substrate in the process chamber group with the first distance and the substrate in the process chamber group with the second distance.

Plasma processing system and operating method of the same

A method for displaying graphic layers is provided. The method includes: receiving a plurality of graphic layers; assigning sequence numbers to the graphic layers according to an overlay order; and displaying the graphic layers in a sequence order according to the sequence numbers.

Method and device for displaying graphic layers

The present invention discloses a substituted pyridine compound represented by formula I, and a pharmaceutically acceptable salt, stereoisomer and tautomer thereof. The compounds of the present invention are useful in the treatment of cancers. 

Substituted pyrimidines as cyclin-dependent kinase inhibitors

An AlGaN/GaN HEMT based on fluorinated graphene passivation and a manufacturing method thereof. Monolayer graphene () is transferred to an AlGaN () surface, is treated by using fluoride ions and then is insulated to thereby replace a conventional nitride passivation layer. Then, a high-k material () is grown on the graphene (), and the high-k material () and the graphene () are jointly used as a gate dielectric for preparing an AlGaN/GaN metal-insulator-semiconductor (MIS) HEMT. Compared with the traditional passivation structure, the graphene () has the advantages of small physical thickness (sub-nanometer scale) and low additional threshold voltage. The structure and the method are simple, the effect is remarkable and the application prospect in technical fields of microelectronics and solid-state electronics is wide.

Fluorinated graphene passivated AlGaN/GaN-based HEMT device and manufacturing method

A system for processing substrates having an atmospheric front end and a vacuum main frame, primary processing chambers attached to the main frame, a loadlock positioned between the front end and the main frame, and at least one secondary processing chamber attached to the loadlock.

Processing chamber, combination of processing chamber and loadlock, and system for processing substrates

A read circuit of storage class memory comprises: an array; a read reference circuit, having the same bit line parasitic parameters as the array, having the same read transmission gate parasitic parameters as the array, used to generate a read reference current; a sense amplifier, providing the same current mirror parasitic parameters as the reference side, used to generate a read current from a selected memory cell, compare the said read current with the said read reference current and output a readout result. In the present invention, the said read current and the said read reference current are generated at the same time, the transient curve of the said read reference current is between the low resistance state read current and the high resistance state read current from an early stage. The present invention largely reduces the read access time, has a good process variation tolerance, has a wide application, and is easy to be used in the practical product.

Read circuit of storage class memory with a read reference circuit, having same bit line parasitic parameters and same read transmission gate parasitic parameters as memory

The present invention discloses a nitrogen-containing fused heterocyclic compound, as well as a preparation method, intermediate, composition and application thereof. The nitrogen-containing fused heterocyclic compound of the present invention as represented by formula (I), as well as the pharmaceutically acceptable salt, enantiomer, diastereomer, tautomer, solvate, metabolite or drug precursor thereof, exhibit a high selectivity and a high inhibitory activity with respect to CDK4 and CDK6 at a molecular level, an excellent inhibitory activity with respect to breast cancer cells at a cellular level, and significant inhibition of tumor cell proliferation associated with cyclin-dependent kinase activity at an animal level. The invention also exhibits a good stability with respect to human or mouse liver microsomes without significant inhibition of metabolic enzymes, good in vivo absorption in mice and rats, a high bioavailability and good druggability.

A method for displaying graphic layers is provided. The method includes: receiving a plurality of graphic layers; assigning sequence numbers to the graphic layers according to an overlay order; assigning a weight value to each graphic layer according to a manner; establishing a layer order according to the sequence numbers and the weight values; and displaying the graphic layers according to the layer order.

A pharmaceutical composition and methods of producing and application of the composition for treating myocardial infarction of a subject are disclosed. The pharmaceutical composition comprises a therapeutically effective amount of at least one synthesized compound selected from the group consisting of SEC, SPC, SBC, SPEC, SAC, SAMC, and SPRC, and a pharmaceutically acceptable carrier.

Method of synthesizing S-allyl-cysteine analogues and their therapeutic application in treating myocardial infarction

Growing community of inventors

Shanghai, China

Qian Wang